Agenda (almost) Complete for Health 2.0 Europe Conference

6-7 April 2010, Paris, France.
Health 2.0 Europe will be a premier conference, featuring the three integral components of Health 2.0 in a unique format where leading examples of Health 2.0 in North America will be compared and contextualized with the latest in European innovation. The three segments are:

1. Online Search and Content
2. Patient and Provider Communities
3. Consumer Self-Management Tools.

To maximize your participation at Health 2.0 Europe, don't miss the opportunity to Exhibit or Sponsor and gain unparalleled exposure to the the most influential leaders in healthcare. Every sponsorship package includes your logo placement on our website, marketing emails and conference materials. Join the existing sponsors, LEEM, Bupa and UCB to get your company in front of this distinguished audience.

The panels and topics will include:

Keynote Addresses: The government view point - How does Health 2.0 fit into the various national IT strategies for EMRs, PHRs and national health and wellness?

Keynote Addresses from:

  • Etienne Caniard, French National Authority for Health France
  • Pieter Vos, Raad voor de Volksgezondheid en Zorg NL

Search & Content - How does the best of vertical search technology resonate in a world where government programs provide significant amounts of health content?

Demonstrations & case studies from:

  • Segolène Ayme, Orphanet EU
  • Frankie Dolan, MedWorm UK
  • Célia Boyer, Health On the Net Foundation Swiss
  • West Shell, Healthline Networks america
  • Steven Krein, Organized Wisdom america
  • Berci Mesko, Webicina Hungary

Patients and Online Communities - The advancement and popularity of patient communities online is an international phenomenon. We'll be examining communities in different cultures, languages and context, and see what impact they have on care delivery in different countries–and what the internationalization of information means for patients and doctors.

The patient perspective from:

  • Roberto Ascione, PagineMediche.it Italy
  • Gilles Frydman, ACOR america
  • Ben Heywood, PatientsLikeMe america
  • Neil Bacon, iWantGreatCare UK

Commentary:

  • Alexander Schachinger, Humboldt University Berlin Germany
  • Susannah Fox, Pew Internet america

Physicians and Online Communities - In the US, physician social networks are in some aspects replacing the function of traditional physician professional organizations. Physician activity online has a long tradition in Europe too. We'll compare and contrast market approaches and results.

The physician perspective from:

  • Daniel Palestrant, Sermo america
  • Miguel Cabrer, Medting Spain
  • Tim Ringrose, Doctors.net.uk UK

Health 2.0 Tools - Consumer tools are an essential piece of the Health 2.0 landscape. Some of the most sophisticated drug, condition and treatment tools are giving patients as much if not more information than their physicians. Their use is already controversial in the US, but how is it playing out in different medical cultures across Europe?

  • Isabelle Adenot, French National Order of Pharmacists France
  • Roy Schoenberg, American Well america
  • David Doherty, 3G Doctor Ireland
  • Roni Zeiger, Google america
  • Sabine Pinedo, stichting Begeleide Zelfzorg (sBZ) NL
  • Neil Williams, Microsoft EU
  • Mohammad Al-Ubaydli, Patients Know Best UK
  • Joris Moolenaar, IPPZ NL

Hospitals, Payers and Health 2.0 - A look at how hospitals and payers are interacting with doctors and patients in the world of Health 2.0.

Demonstrations & commentary from:

  • Paul Hodgkin, PatientOpinion UK
  • Don Kemper, Healthwise america
  • Jean-Pascal Del Bano, Le Guide Santé France

Pharma and Health 2.0 - How is Health 2.0 affecting Pharma? A look at how pharmaceutical companies are connecting with doctors and patients in new ways, and how Health 2.0 is changing the way they're conducting clinical research.

Discussion & case studies from:

  • Daniel Ghinn, Creation Interactive UK
  • Sylvie St-Laurent, Pfizer France
  • Len Starnes, Bayer Health Germany
  • Sophie Kune, ParleAvecElles France
  • René Hansen, UCB belgium

Looking Ahead for Health 2.0 - Discoveries and lessons from the conference.

For further information and registration, please visit:
http://www.health2con.com/paris2010/

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech advance COVID-19 vaccine strat…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to...

New needle-free nasal vaccine shows promise for CO…

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mB...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Disparities in United States COVID-19 vaccine dist…

When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populat...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

GSK signs agreement to support pandemic preparedne…

GSK plc (LSE/NYSE: GSK) announced it had signed a framework contract with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA) for t...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

Scientists develop new biomimetic formulation for …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore ...